Document Detail

Biomarkers in Parkinson's disease: a venture capitalist's perspective.
MedLine Citation:
PMID:  20945985     Owner:  NLM     Status:  In-Process    
The emergence of biomarkers linking disease and treatment effects in a clear manner presents an opportunity to change the current drug development paradigm, which could lead to more cost-efficient and higher-quality clinical trials. This has raised the hopes of venture capital investors, who may be able to better navigate the stormy and risky sea of early-stage life science investments, to find a way out of the current funding crisis for novel, nonvalidated drugs and their clinical development. The following survey paints a snapshot of the current perception of biomarkers as a paradigm changer in the eyes of the venture capital community.
Jens W Eckstein
Related Documents :
10744105 - Chiral switches.
24968775 - Life-long consequences of juvenile exposure to psychotropic drugs on brain and behavior.
24625135 - Over-diagnosed and over-treated: a survey of australian public attitudes towards the ac...
2141275 - Development of folliculitis and pyoderma gangrenosum in association with abdominal pain...
9366895 - Assessing compliance to antihypertensive medications using computer-based pharmacy reco...
7353475 - Drug use and drug problems among teenagers in a household sample.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Biomarkers in medicine     Volume:  4     ISSN:  1752-0371     ISO Abbreviation:  Biomark Med     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101312535     Medline TA:  Biomark Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  731-5     Citation Subset:  IM    
TVM Capital, 101 Arch Street, Boston, MA 02030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Biomarkers in Parkinson's disease: a funder's perspective.
Next Document:  Vascular dysfunction biomarkers are elevated in children with HIV.